MedPath

treatment of enlargement of prostatic by Closing the feeder vessels

Not Applicable
Conditions
Hyperplasia of Prostate
Benign Prostatic Hyperplasia.
Registration Number
IRCT2015100318457N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
12
Inclusion Criteria

Men aged over 60 years having benign prostatic hyperplasia; no respond to medical treatment after 6 months, having sexual dysfunction, having maximum flow rate (Qmax) less than 12 mm/s in urine; ?;acute urinary retention . Exclusion criteria: malignancy; tortuosity and atherosclerotic iliac artery; having any indication for renal surgery such as hematuria, bladder diverticula, stones

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Q max. Timepoint: befor intrvention and 1,3,6 months after intervention. Method of measurement: uroflowmetry.;IPSS. Timepoint: befor intrvention and 1,3,6 months after intervention. Method of measurement: Questionnaire.;Prostat size. Timepoint: befor intrvention and 1,3,6 months after intervention. Method of measurement: Sonography.;PSA level. Timepoint: befor intrvention and 1,3,6 months after intervention. Method of measurement: lab.
Secondary Outcome Measures
NameTimeMethod
Contrast media side effectS. Timepoint: during procedure and after 24 hours. Method of measurement: question from patient and clinical examination.;Sexual dysfunction. Timepoint: 6 months after surgery. Method of measurement: question from patients.;Dont response to embolization and need to surgery. Timepoint: after 6 months. Method of measurement: question from patients.
© Copyright 2025. All Rights Reserved by MedPath